KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2025)

Twist Bioscience (TWST) has disclosed Gains from Investment Securities for 9 consecutive years, with $184000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 820.0% to $184000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $164000.0 through Dec 2025, down 50.6% year-over-year, with the annual reading at -$120000.0 for FY2023, 148.78% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $184000.0 at Twist Bioscience, up from -$622000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $19.4 million in Q2 2022, with the low at -$19.2 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is -$98263.2, with a median of $20000.0 recorded in 2024.
  • The sharpest move saw Gains from Investment Securities plummeted 19650.0% in 2021, then soared 19966.67% in 2025.
  • Over 5 years, Gains from Investment Securities stood at -$395000.0 in 2021, then dropped by 26.33% to -$499000.0 in 2022, then surged by 37.47% to -$312000.0 in 2023, then surged by 106.41% to $20000.0 in 2024, then surged by 820.0% to $184000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $184000.0, -$622000.0, and $602000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.